Supreme Court Preserves Telehealth And Mail Access To Mifepristone — For Now

Supreme Court Preserves Telehealth And Mail Access To Mifepristone — For Now The court intervened at the behest of two manufacturers of mifepristone on Thursday, after the U.S. Court of Appeals for the Fifth Circuit restricted access to the drug nationwide. The order means that the Fifth Circuit’s decision will remain blocked while litigation continues in the lower courts. The issue could eventually return to the high court. https://kffhealthnews.org/morning-breakout/reproductive-health-3/